Stocks BILL Financial statements
Financial statementsBILL Holdings, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 9 fiscal years, taken from the XBRL data BILL Holdings, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2018 | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 64.9 | 108 | 158 | 238 | 642 | 1,058 | 1,290 | 1,463 | 1,653 |
| Cost of revenue | 19.4 | 29.9 | 39.1 | 61.8 | 145 | 194 | 235 | 272 | 315 |
| Gross profit | 45.5 | 78.4 | 118 | 176 | 497 | 864 | 1,056 | 1,190 | 1,338 |
| Research and development | 18 | 28.9 | 53 | 89.5 | 220 | 315 | 337 | 340 | 301 |
| Selling and marketing | 19.3 | 30.1 | 45.1 | 67.9 | 307 | 516 | 479 | 544 | 616 |
| General and administrative | 16 | 29.2 | 53.5 | 128 | 221 | 249 | 278 | 282 | 299 |
| Operating expenses | 53.3 | 88.2 | 153 | 290 | 814 | 1,160 | 1,230 | 1,271 | 1,411 |
| Operating income | -7.82 | -9.8 | -34.2 | -114 | -317 | -296 | -174 | -80.6 | -73.4 |
| Interest expense | 0.43 | 0.83 | 0.23 | 28.2 | 9.42 | 15.2 | 19.2 | ||
| Interest income | 1.06 | 3.21 | 4.09 | 2.99 | 6.69 | 91.3 | 122 | ||
| Other non-operating income | 0.63 | 2.33 | 3.16 | -25.4 | -13.9 | 72.9 | 148 | 111 | 63.3 |
| Pre-tax income | -7.19 | -7.47 | -31 | -139 | -331 | -223 | -26.3 | 30.4 | -10.1 |
| Income tax | 0.01 | -0.16 | 0.05 | -40.6 | -4.32 | 0.81 | 2.56 | 6.61 | 1.11 |
| Net income | -7.2 | -7.31 | -31.1 | -98.7 | -326 | -224 | -28.9 | 23.8 | -11.2 |
| EBITDA | -5.5 | -6.65 | -33.1 | -109 | -305 | -280 | -151 | -53.1 | -17.5 |
| EPS, basic | -1.01 | -0.94 | -0.70 | -1.19 | -3.21 | -2.11 | -0.27 | 0.23 | -0.11 |
| EPS, diluted | -1.01 | -0.94 | -0.70 | -1.19 | -3.21 | -2.11 | -0.27 | -0.07 | -0.11 |
| Shares, basic (weighted) | 7.16 | 7.8 | 44.1 | 82.8 | 102 | 106 | 106 | 104 | 99.9 |
| Shares, diluted (weighted) | 7.16 | 7.8 | 44.1 | 82.8 | 102 | 106 | 106 | 104 | 99.9 |
Balance sheet
| FY2018 | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 22.4 | 90.3 | 574 | 510 | 1,597 | 1,617 | 986 | 1,038 | 1,031 |
| Short-term investments | 72 | 124 | 655 | 1,108 | 1,043 | 602 | 1,180 | 906 | |
| Receivables | 4.4 | 4.25 | 18.2 | 24 | 28.2 | 28 | 32.3 | 31 | |
| Other current assets | 12.3 | 26.8 | 67.2 | 151 | 170 | 297 | 258 | 302 | |
| Total current assets | 1,513 | 2,379 | 3,606 | 6,279 | 6,673 | 6,315 | 7,239 | 7,435 | |
| Property, plant and equipment | 6.56 | 13.9 | 48.9 | 57 | 81.6 | 88 | 117 | 145 | |
| Lease right-of-use assets | 71.9 | 76.4 | 69 | 59.4 | 56.1 | 47.8 | |||
| Goodwill | 0 | 1,772 | 2,363 | 2,397 | 2,397 | 2,397 | 2,397 | ||
| Intangible assets | 417 | 433 | 361 | 281 | 223 | 162 | |||
| Other non-current assets | 6.64 | 10.7 | 52.9 | 47.7 | 54.4 | 38.6 | 33.2 | 31.6 | |
| Total assets | 1,526 | 2,404 | 5,969 | 9,256 | 9,636 | 9,179 | 10,064 | 10,218 | |
| Accounts payable | 5.06 | 3.48 | 11.9 | 9.95 | 8.52 | 7.45 | 16.3 | 9.64 | |
| Accrued liabilities | 6.56 | 10.8 | 72 | 120 | 195 | 300 | 252 | 387 | |
| Deferred revenue | 3.47 | 5.89 | 12.8 | 31.9 | 26.3 | 17 | 22.4 | 19.4 | |
| Total current liabilities | 1,349 | 1,677 | 2,326 | 3,409 | 3,753 | 4,063 | 4,589 | 4,925 | |
| Lease liabilities | 86.6 | 82.7 | 72.5 | 62.8 | 58.4 | 48.5 | |||
| Other non-current liabilities | 1.45 | 13.8 | 35 | 20.8 | 18.9 | 0.57 | 1.58 | 0.78 | |
| Total liabilities | 1,353 | 1,693 | 3,440 | 5,212 | 5,550 | 5,045 | 6,150 | 6,688 | |
| Total debt | 989 | 1,773 | 1,840 | 914 | 1,714 | 1,836 | |||
| Paid-in capital | 14.7 | 857 | 2,777 | 4,599 | 4,947 | 5,233 | 5,415 | 5,626 | |
| Retained earnings | -118 | -149 | -247 | -545 | -856 | -1,097 | -1,511 | -2,089 | |
| Other comprehensive income | 0.33 | 2.42 | -0.1 | -10.2 | -4.49 | -1.89 | 10.2 | -6.42 | |
| Shareholders' equity | -102 | -103 | 711 | 2,530 | 4,044 | 4,086 | 4,134 | 3,914 | 3,531 |
| Total equity | -102 | -103 | 711 | 2,530 | 4,044 | 4,086 | 4,134 | 3,914 | 3,531 |
| Total liabilities and equity | 1,526 | 2,404 | 5,969 | 9,256 | 9,636 | 9,179 | 10,064 | 10,218 | |
| Shares outstanding | 0.01 | 94.5 | 105 | 107 | 107 | 103 | 92.1 |
Cash flow statement
| FY2018 | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Net income | -7.2 | -7.31 | -31.1 | -98.7 | -326 | -224 | -28.9 | 23.8 | -11.2 |
| Depreciation and amortization | 2.31 | 3.15 | 1.14 | 4.87 | 11.5 | 15.5 | 23.2 | 27.5 | 55.9 |
| Stock-based compensation | 1.55 | 4.08 | 18.1 | 68.3 | 197 | 314 | 248 | 243 | 230 |
| Deferred income tax | -0.18 | 0 | -40.6 | -4.07 | -1.36 | -0.36 | -0.08 | 0.28 | |
| Change in receivables | -0.28 | -2.1 | -1.61 | -6.54 | -3.03 | -4.48 | 0.07 | -4.46 | 1.42 |
| Change in payables | -0.56 | 3.17 | -1.6 | 7.42 | -3.77 | -1.69 | -1.13 | 8.21 | -5.87 |
| Cash from operations | -8.36 | -3.95 | -4.43 | 4.62 | -18.1 | 188 | 279 | 351 | 416 |
| Capital expenditures | -1.31 | -2.74 | -11.4 | -18.9 | -5.38 | -7.59 | -0.98 | -4.34 | -3.33 |
| Acquisitions | 0 | -556 | -144 | -28.9 | 0 | 0 | |||
| Cash from investing | -418 | -96.1 | -249 | -1,427 | -1,127 | 259 | -409 | -817 | -28.6 |
| Debt issued | 0 | 1,129 | 560 | 0 | 0 | 1,400 | 0 | ||
| Stock issued | 0.69 | 1.7 | 0 | 8.86 | 12.8 | 17.9 | 16.5 | 11.6 | 11.9 |
| Share buybacks | 0 | 0 | -87.6 | -212 | -430 | -560 | |||
| Cash from financing | 326 | 492 | 863 | 1,640 | 2,879 | 235 | -743 | 667 | -173 |
| Exchange rate effect | 0 | 0 | -0.15 | -0.04 | -0.24 | -0.29 | -0.05 | ||
| Net change in cash | -99.9 | 392 | 609 | 217 | 1,733 | 682 | -873 | 199 | 214 |
| Free cash flow | -9.67 | -6.69 | -15.9 | -14.3 | -23.5 | 180 | 278 | 346 | 412 |
| Interest paid | 0.44 | 0.87 | 0.17 | 0.11 | 4.87 | 7.44 | 12.6 | 13.8 | 19 |
| Income taxes paid | 0 | 0 | 1.27 | 5.63 | 6.32 | 1.11 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 80.9% | Gross profit / revenue. |
| Operating margin | -4.4% | Operating income / revenue. |
| EBITDA margin | -1.1% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -0.6% | Pre-tax income / revenue. |
| Net margin | -0.7% | Net income / revenue. |
| FCF margin | 25.0% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 25.2% | Cash from operations / revenue. |
| Return on equity (ROE) | -0.3% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -0.1% | Net income / average total assets. |
| Return on invested capital (ROIC) | -1.3% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 18.2% | Research and development expense / revenue. |
| Stock-based pay / revenue | 13.9% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 0.2% | Capital expenditures / revenue. |
| D&A / revenue | 3.4% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 13.0% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 16.0% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 47.3% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 12.4% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 15.7% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 50.0% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | -147.2% | Net income vs the same period a year earlier. Only from a positive base. |
| Operating cash flow growth, 1y | 18.6% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 30.3% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 145.9% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 19.1% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 31.8% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value growth, 1y | -9.8% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -4.8% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 6.9% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 1.5% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 2.0% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 11.4% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | -3.8% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -1.9% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 3.8% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.51x | Current assets / current liabilities. |
| Quick ratio | 0.40x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.39x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.52x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 18.0% | Total debt / total assets. |
| Liabilities / assets | 65.4% | Total liabilities / total assets. |
| Net debt | -$101.4M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Working capital | $2.51B | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 25.0% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $971.9M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.16x | Revenue / average total assets. |
| Fixed asset turnover | 12.6x | Revenue / average property, plant and equipment. |
| Receivables turnover | 52.2x | Revenue / average receivables. |
| Days sales outstanding | 7 days | 365 x average receivables / revenue. |
| Days payables | 15 days | 365 x average accounts payable / cost of revenue. |
| Capex / operating cash flow | 0.8% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$0.11 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | -$0.11 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $16.55 | Revenue / diluted weighted shares. |
| FCF per share | $4.13 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $4.16 | Cash from operations / diluted weighted shares. |
| Book value per share | $38.35 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $10.56 | Tangible book value / shares outstanding. |
| Cash per share | $21.05 | (Cash + short-term investments) / shares outstanding. |
| Buybacks / FCF | 135.9% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $4.41B | Share price x shares outstanding. |
| Enterprise value | $4.31B | Market cap + total debt - cash - short-term investments. |
| P/S | 2.67x | Market cap / revenue. |
| P/B | 1.25x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 4.53x | Market cap / tangible book value, when positive. |
| P/FCF | 10.7x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 10.6x | Market cap / cash from operations, when positive. |
| EV/Sales | 2.60x | Enterprise value / revenue. |
| EV/FCF | 10.4x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 9.4% | Free cash flow / market cap. |
| Earnings yield | -0.3% | Net income / market cap (the inverse of P/E). |
| Shareholder yield | 12.7% | (Dividends paid + share buybacks) / market cap. |
What was BILL Holdings, Inc.'s revenue in fiscal 2026?
BILL Holdings, Inc. reported revenue of $1.65B for fiscal 2026, 13% higher than the year before.
Was BILL Holdings, Inc. profitable in fiscal 2026?
No. It reported a net loss of $11.2M.
How much free cash flow did BILL Holdings, Inc. generate in fiscal 2026?
Cash from operations of $415.8M minus capital expenditures of $3.3M left free cash flow of $412.5M.